These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 10835102

  • 1. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.
    Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H.
    Pharmacol Rev; 2000 Jun; 52(2):269-324. PubMed ID: 10835102
    [Abstract] [Full Text] [Related]

  • 2. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
    Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H.
    Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
    [Abstract] [Full Text] [Related]

  • 3. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ, Basille M, Vaudry D, Fournier A, Vaudry H.
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [Abstract] [Full Text] [Related]

  • 4. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 5. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.
    Arimura A.
    Jpn J Physiol; 1998 Oct; 48(5):301-31. PubMed ID: 9852340
    [Abstract] [Full Text] [Related]

  • 6. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
    Hashimoto H.
    Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
    [Abstract] [Full Text] [Related]

  • 7. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 8. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G.
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [Abstract] [Full Text] [Related]

  • 9. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D, Vaudry H, Grumolato L, Turquier V, Fournier A, Jégou S, Anouar Y.
    Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
    [Abstract] [Full Text] [Related]

  • 10. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK.
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [Abstract] [Full Text] [Related]

  • 11. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Busto R, Sánchez-Chapado M, Guijarro LG, Prieto JC.
    Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
    [Abstract] [Full Text] [Related]

  • 12. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C.
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [Abstract] [Full Text] [Related]

  • 13. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 14. Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity.
    Schäfer H, Zheng J, Morys-Wortmann C, Fölsch UR, Schmidt WE.
    Regul Pept; 1999 Feb 05; 79(2-3):83-92. PubMed ID: 10100920
    [Abstract] [Full Text] [Related]

  • 15. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B.
    J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K, Connell TD, Higgins D.
    J Neurosci; 2002 Aug 01; 22(15):6560-9. PubMed ID: 12151535
    [Abstract] [Full Text] [Related]

  • 17. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
    Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki J, Seino S.
    Proc Natl Acad Sci U S A; 1994 Mar 29; 91(7):2679-83. PubMed ID: 8146174
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA.
    Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463
    [Abstract] [Full Text] [Related]

  • 19. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M.
    Ann N Y Acad Sci; 2000 Jun 01; 921():92-102. PubMed ID: 11193883
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
    Li M, Funahashi H, Mbikay M, Shioda S, Arimura A.
    Endocrine; 2004 Feb 01; 23(1):59-75. PubMed ID: 15034198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.